跳至主要内容
临床试验/NCT00122915
NCT00122915终止3 期

A Prospective, Randomized, Double Blind, Crossover, Multi-center Study to Evaluate the Safety and the Efficacy of Motor Cortex Stimulation With the Cortical Stimulation Lead Model 2976 in Patients With Neuropathic Pain

MedtronicNeuro22 个研究点 分布在 4 个国家目标入组 104 人开始时间: 2005年6月最近更新:
适应症

试验速览

阶段
3 期
状态
终止
入组人数
104
试验地点
22
主要终点
Adverse events reports

研究概览

简要总结

The CONCEPT study has been designed to evaluate the safety and the efficacy of Motor Cortex Stimulation (MCS) with a new cortical lead (circular lead, eight electrodes, Medtronic Inc, Minneapolis, USA) in the treatment of intractable neuropathic pain, in particular for central post-stroke pain (CPSP) and trigeminal neuropathic pain (TGN)/facial pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • CPSP or TGN/facial pain refractory to other medical treatments
  • Pain > 1 year prior to baseline
  • Pain intensity with an average daily VAS score > 5 demonstrated by 12 ratings across 4 days
  • Stable pain medication for > 1 month prior to baseline

排除标准

  • CPSP with important paresis/severe motor deficit in the area of pain
  • TGN/facial pain with complete deafferentation pain
  • Atypical facial pain, i.e. when objective evidence for neuropathic facial pain syndromes is lacking and when specific psychological and behavioral factors can be identified
  • Pain associated with malignant neoplastic disease anywhere in the body or head
  • History of epilepsy
  • Presence of a deterioration of cognitive functions

结局指标

主要结局

Adverse events reports

Pain assessed by Visual Analogue Scale (VAS)

次要结局

  • Quality of life
  • Analgesic, sedative or psychoactive medication intake
  • Disability

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (22)

Loading locations...

相似试验

CONCEPT: Crossover Efficacy Pain Trial in Motor... | 临床试验